Cure My Disease

Don't miss your cure!

 Log in / Sign up

90,000-Person kidney study aims to unlock disease secrets

NCT ID NCT05188885

Knowledge-focused Sponsor: Guangdong Provincial People's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study will follow 90,000 people in China, including those with chronic kidney disease (CKD) and those at risk, to track how the disease develops and worsens over time. Researchers will collect real-world data to better understand CKD and improve prevention strategies. No treatments or drugs are being tested.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide valuable insights to improve prevention and management of chronic kidney disease in China.
What could go wrong
This is an observational registry, not a treatment trial. It will not test any new drug or therapy, so it cannot directly lead to a cure or treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 90,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2021

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Enrolled based on both hospitals and communities.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients diagnosed with CKD as defined in the KDIGO Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease 2012 Edition; * Non-CKD patients with hypertension, diabetes, hyperlipidemia, hyperuricemia, eGFR (CKD-EPI formula) of 60-89 ml/min/1.73m\^2 and other risk factors for CKD; * Healthy population. * Signed the informed consent voluntarily. Exclusion Criteria: 。Patients identified to be unsuitable for enrollment by the study physician.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fogang County People's Hospital

    NOT_YET_RECRUITING

    Qingyuan, Guangdong, China

  • Ganzhou Municipal Hospital

    NOT_YET_RECRUITING

    Ganzhou, Jiangxi, China

  • Guangdong Provincial Peoples Hospital

    RECRUITING

    Guangzhou, Guangdong, China

  • People's Hospital of Yingde

    NOT_YET_RECRUITING

    Qingyuan, Guangdong, China

  • The First Affiliated Hospital of Sun Yat-sen University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, China

  • The Second People's Hospital of Nanhai District in Foshan City

    NOT_YET_RECRUITING

    Foshan, Guangdong, China

  • Wuhua County People's Hospital

    NOT_YET_RECRUITING

    Meizhou, Guangdong, China

  • Zhuhai Golden Bay Central Hospital

    NOT_YET_RECRUITING

    Zhuhai, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.